174 related articles for article (PubMed ID: 26563147)
1. A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Bruce J; Bruce A; Lynch S; Strober L; O'Bryan S; Sobotka D; Thelen J; Ness A; Glusman M; Goggin K; Bradley-Ewing A; Catley D
J Behav Med; 2016 Apr; 39(2):276-87. PubMed ID: 26563147
[TBL] [Abstract][Full Text] [Related]
2. Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention.
Thelen J; Bruce A; Catley D; Lynch S; Goggin K; Bradley-Ewing A; Glusman M; Norouzinia A; Strober L; Bruce J
J Behav Med; 2018 Apr; 41(2):253-260. PubMed ID: 29124557
[TBL] [Abstract][Full Text] [Related]
3. Motivational interviewing and cognitive behaviour therapy for anxiety following traumatic brain injury: a pilot randomised controlled trial.
Hsieh MY; Ponsford J; Wong D; Schönberger M; Taffe J; McKay A
Neuropsychol Rehabil; 2012; 22(4):585-608. PubMed ID: 22632385
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of motivational interviewing and cognitive behavioral therapy for anxiety and depression symptoms following traumatic brain injury.
Ponsford J; Lee NK; Wong D; McKay A; Haines K; Alway Y; Downing M; Furtado C; O'Donnell ML
Psychol Med; 2016 Apr; 46(5):1079-90. PubMed ID: 26708017
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Randomized Controlled Trial to Assess the Impact of Motivational Interviewing on Initiating Behavioral Therapy for Migraine.
Minen MT; Sahyoun G; Gopal A; Levitan V; Pirraglia E; Simon NM; Halpern A
Headache; 2020 Feb; 60(2):441-456. PubMed ID: 31981227
[TBL] [Abstract][Full Text] [Related]
6. Motivational Interviewing as an Adjunct to Cognitive Behavioral Therapy for Anxiety.
Barrera TL; Smith AH; Norton PJ
J Clin Psychol; 2016 Jan; 72(1):5-14. PubMed ID: 26630412
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial for aggression and substance use involvement among Veterans: Impact of combining Motivational Interviewing, Cognitive Behavioral Treatment and telephone-based Continuing Care.
Chermack ST; Bonar EE; Goldstick JE; Winters J; Blow FC; Friday S; Ilgen MA; Rauch SAM; Perron BE; Ngo QM; Walton MA
J Subst Abuse Treat; 2019 Mar; 98():78-88. PubMed ID: 30665608
[TBL] [Abstract][Full Text] [Related]
8. Reducing dropout in acceptance and commitment therapy, mindfulness-based cognitive therapy, and problem-solving therapy for chronic pain and cancer patients using motivational interviewing.
Malins S; Biswas S; Rathbone J; Vogt W; Pye N; Levene J; Moghaddam N; Russell J
Br J Clin Psychol; 2020 Sep; 59(3):424-438. PubMed ID: 32478862
[TBL] [Abstract][Full Text] [Related]
9. Discontinuing Treatment Against Medical Advice: The Role of Perceived Autonomy Support From Providers in Relapsing-Remitting Multiple Sclerosis.
Glusman M; Bruce A; Thelen J; Smith J; Lynch S; Catley D; Bennett KK; Bruce J
Ann Behav Med; 2019 Mar; 53(3):283-289. PubMed ID: 29771271
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
Bonafede MM; Johnson BH; Wenten M; Watson C
Clin Ther; 2013 Oct; 35(10):1501-12. PubMed ID: 24139422
[TBL] [Abstract][Full Text] [Related]
11. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.
Mohr DC; Likosky W; Bertagnolli A; Goodkin DE; Van Der Wende J; Dwyer P; Dick LP
J Consult Clin Psychol; 2000 Apr; 68(2):356-61. PubMed ID: 10780138
[TBL] [Abstract][Full Text] [Related]
12. Reasons for nonadherence and response to treatment in an adherence intervention trial for relapsing-remitting multiple sclerosis patients.
Schoor R; Bruce A; Bruce J; Goggin K; Schanfarber B; Bradley-Ewing A; Thelen J; Glusman M; Lynch SG; Strober L; Catley D
J Clin Psychol; 2019 Mar; 75(3):380-391. PubMed ID: 30485422
[TBL] [Abstract][Full Text] [Related]
13. Client interpersonal impacts as mediators of long-term outcome in cognitive-behavioral therapy integrated with motivational interviewing for generalized anxiety disorder.
Constantino MJ; Romano FM; Coyne AE; Westra HA; Antony MM
Psychother Res; 2018 Nov; 28(6):861-872. PubMed ID: 28337945
[TBL] [Abstract][Full Text] [Related]
14. Telephone counseling and home telehealth monitoring to improve medication adherence: results of a pilot trial among individuals with multiple sclerosis.
Turner AP; Sloan AP; Kivlahan DR; Haselkorn JK
Rehabil Psychol; 2014 May; 59(2):136-46. PubMed ID: 24708232
[TBL] [Abstract][Full Text] [Related]
15. [Motivational interviewing and cognitive behavior therapy for smoking cessation].
Kawai A; Kano M; Sato T
Nihon Rinsho; 2013 Mar; 71(3):493-8. PubMed ID: 23631242
[TBL] [Abstract][Full Text] [Related]
16. Development of a motivational interviewing programme as a prelude to CBT for anxiety following traumatic brain injury.
Hsieh MY; Ponsford J; Wong D; Schönberger M; McKay A; Haines K
Neuropsychol Rehabil; 2012; 22(4):563-84. PubMed ID: 22632450
[TBL] [Abstract][Full Text] [Related]
17. Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data.
Caon C; Saunders C; Smrtka J; Baxter N; Shoemaker J
J Neurosci Nurs; 2010 Oct; 42(5 Suppl):S5-9. PubMed ID: 21049828
[TBL] [Abstract][Full Text] [Related]
18. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study.
DiIorio C; Resnicow K; McDonnell M; Soet J; McCarty F; Yeager K
J Assoc Nurses AIDS Care; 2003; 14(2):52-62. PubMed ID: 12698766
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial examining the efficacy of motivational counseling with observed therapy for antiretroviral therapy adherence.
Goggin K; Gerkovich MM; Williams KB; Banderas JW; Catley D; Berkley-Patton J; Wagner GJ; Stanford J; Neville S; Kumar VK; Bamberger DM; Clough LA
AIDS Behav; 2013 Jul; 17(6):1992-2001. PubMed ID: 23568228
[TBL] [Abstract][Full Text] [Related]
20. Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis.
Stratos K; McGarragle K; Thistle J; Vyas MV; Lee L
Mult Scler Relat Disord; 2020 Jun; 41():102016. PubMed ID: 32135497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
